• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂质体的雾化。III. 操作条件和局部环境的影响。

Nebulization of liposomes. III. The effects of operating conditions and local environment.

作者信息

Niven R W, Carvajal T M, Schreier H

机构信息

Amgen Inc., Thousand Oaks, California 91320.

出版信息

Pharm Res. 1992 Apr;9(4):515-20. doi: 10.1023/a:1015844430695.

DOI:10.1023/a:1015844430695
PMID:1495897
Abstract

Multilamellar liposomes (MLV) of saturated phosphatidylcholine and dipalmitoyl phosphatidylglycerol (DPPG) (9:1 mole ratio) containing 5,6-carboxyfluorescein (CF) were prepared and extruded through 1.0-micron polycarbonate membranes. Diluted aqueous dispersions were aerosolized for a total of 80 min using a Collison nebulizer under a variety of conditions. The effects of air pressure, temperature, buffer osmotic strength, and pH on nebulized liposome dispersions were studied. Changes in air pressure produced large changes in the percentage release of CF and ranged from 1.3% (4 psig) to 88.2% (50 psig) after 80 min of nebulization. The temperature of the nebulizer dispersions dropped during experiments. The extent of the temperature drop varied according to the air pressure used and ranged from 5 degrees C (4 psig) to 11 degrees C (greater than or equal to 30 psig). The temperature of dispersions caused no increase in CF release until the gel-to-liquid crystalline transition temperature was exceeded (54.6 degrees C), whereupon a 20% increase in leakage was observed after 80 min of nebulization. Aerosol mass output was relatively unaffected by the starting temperature of experiments when conducted within the ambient temperature range. Leakage from the liposomes was increased in hypotonic solution but decreased in hypertonic solutions. At a buffer pH of 2.85 the percentage leakage of CF was increased approximately 18% compared to that at pH 7.2 and pH 10.75. Results show that the stability of liposomes composed of saturated phosphatidylcholine and DPPG (9:1 mole ratio) is affected by the operating and environmental conditions under which aerosolization takes place, with air pressure having the greatest effect.

摘要

制备了含有5,6 - 羧基荧光素(CF)的饱和磷脂酰胆碱和二棕榈酰磷脂酰甘油(DPPG)(摩尔比9:1)的多层脂质体(MLV),并通过1.0微米的聚碳酸酯膜挤出。在各种条件下,使用科里森雾化器将稀释的水分散体雾化总共80分钟。研究了气压、温度、缓冲液渗透强度和pH对雾化脂质体分散体的影响。气压变化导致CF释放百分比发生很大变化,雾化80分钟后,释放百分比范围从1.3%(4 psig)到88.2%(50 psig)。实验过程中雾化器分散体的温度下降。温度下降程度根据所用气压而变化,范围从5摄氏度(4 psig)到11摄氏度(大于或等于30 psig)。分散体温度在超过凝胶 - 液晶转变温度(54.6摄氏度)之前不会导致CF释放增加,在此温度以上,雾化80分钟后观察到泄漏增加20%。在环境温度范围内进行实验时,气溶胶质量输出相对不受实验起始温度的影响。脂质体在低渗溶液中的泄漏增加,而在高渗溶液中泄漏减少。在缓冲液pH为2.85时,CF的泄漏百分比与pH 7.2和pH 10.75时相比增加了约18%。结果表明,由饱和磷脂酰胆碱和DPPG(摩尔比9:1)组成的脂质体的稳定性受雾化发生时的操作和环境条件影响,其中气压影响最大。

相似文献

1
Nebulization of liposomes. III. The effects of operating conditions and local environment.脂质体的雾化。III. 操作条件和局部环境的影响。
Pharm Res. 1992 Apr;9(4):515-20. doi: 10.1023/a:1015844430695.
2
Nebulization of liposomes. I. Effects of lipid composition.脂质体的雾化。I. 脂质组成的影响。
Pharm Res. 1990 Nov;7(11):1127-33. doi: 10.1023/a:1015924124180.
3
Physical stability and aerosol properties of liposomes delivered using an air-jet nebulizer and a novel micropump device with large mesh apertures.使用空气喷射雾化器和具有大网孔的新型微泵装置递送的脂质体的物理稳定性和气溶胶特性。
Int J Pharm. 2007 Apr 4;334(1-2):62-70. doi: 10.1016/j.ijpharm.2006.10.022. Epub 2006 Oct 21.
4
Nebulization of liposomes. II. The effects of size and modeling of solute release profiles.脂质体雾化。II. 溶质释放曲线的大小和模型的影响。
Pharm Res. 1991 Feb;8(2):217-21. doi: 10.1023/a:1015896121377.
5
Hydraulic high-pressure nebulization of solutions and dispersions for respiratory drug delivery.用于呼吸道药物递送的溶液和分散体的液压高压雾化
Pharm Dev Technol. 2000;5(1):105-13. doi: 10.1081/pdt-100100525.
6
Prediction and experimental determination of solute output from a Collison nebulizer.碰撞式雾化器溶质输出量的预测与实验测定
J Pharm Sci. 1994 Jul;83(7):1047-51. doi: 10.1002/jps.2600830724.
7
Formulations generated from ethanol-based proliposomes for delivery via medical nebulizers.由基于乙醇的前体脂质体制备的制剂,用于通过医用雾化器给药。
J Pharm Pharmacol. 2006 Jul;58(7):887-94. doi: 10.1211/jpp.58.7.0002.
8
Vibrating-mesh nebulization of liposomes generated using an ethanol-based proliposome technology.基于乙醇前体脂质体技术的脂质体的振动网雾化。
J Liposome Res. 2011 Jun;21(2):173-80. doi: 10.3109/08982104.2010.505574. Epub 2010 Aug 4.
9
Measuring nebulizer output. Aerosol production vs gravimetric analysis.测量雾化器输出量。气溶胶产生量与重量分析
Chest. 1997 May;111(5):1361-5. doi: 10.1378/chest.111.5.1361.
10
Stabilization of aerosolized IFN-gamma by liposomes.脂质体对雾化干扰素-γ的稳定作用。
Int J Pharm. 1999 Oct 25;188(2):165-72. doi: 10.1016/s0378-5173(99)00218-5.

引用本文的文献

1
New Gel Approaches for the Transdermal Delivery of Meloxicam.用于美洛昔康经皮给药的新型凝胶制剂
Gels. 2025 Jun 26;11(7):500. doi: 10.3390/gels11070500.
2
Nano-Formulations for Pulmonary Delivery: Past, Present, and Future Perspectives.肺部给药的纳米制剂:过去、现在与未来展望
Pharmaceutics. 2024 Jan 24;16(2):161. doi: 10.3390/pharmaceutics16020161.
3
Efficacy of Combined Rifampicin Formulations Delivered by the Pulmonary Route to Treat Tuberculosis in the Guinea Pig Model.经肺途径给药的联合利福平制剂治疗豚鼠模型结核病的疗效

本文引用的文献

1
The osmotic response of large unilamellar vesicles studied by quasielastic light scattering.通过准弹性光散射研究的大单层囊泡的渗透响应。
Biochim Biophys Acta. 1986 Nov 17;862(2):379-86. doi: 10.1016/0005-2736(86)90241-5.
2
Room temperature influences output from the Wright jet nebulizer.室温会影响赖特喷射雾化器的输出。
Eur Respir J. 1989 Jul;2(7):681-4.
3
Nebulization of liposomes. I. Effects of lipid composition.脂质体的雾化。I. 脂质组成的影响。
Pharmaceutics. 2021 Aug 21;13(8):1309. doi: 10.3390/pharmaceutics13081309.
4
Inhaled chemotherapy in lung cancer: future concept of nanomedicine.肺癌的吸入化疗:纳米医学的未来概念。
Int J Nanomedicine. 2012;7:1551-72. doi: 10.2147/IJN.S29997. Epub 2012 Mar 22.
5
A dry powder formulation of liposome-encapsulated recombinant secretory leukocyte protease inhibitor (rSLPI) for inhalation: preparation and characterisation.脂质体包封的重组分泌型白细胞蛋白酶抑制剂(rSLPI)干粉吸入制剂的制备与表征。
AAPS PharmSciTech. 2010 Sep;11(3):1411-21. doi: 10.1208/s12249-010-9500-2. Epub 2010 Sep 15.
6
Effect of cholesterol on the properties of spray-dried lysozyme-loaded liposomal powders.胆固醇对喷雾干燥载脂蛋白脂质体粉末性质的影响。
AAPS PharmSciTech. 2010 Jun;11(2):832-42. doi: 10.1208/s12249-010-9442-8. Epub 2010 May 13.
7
Two disaccharides and trimethylamine N-oxide affect Abeta aggregation differently, but all attenuate oligomer-induced membrane permeability.两种二糖和氧化三甲胺对β-淀粉样蛋白(Aβ)聚集的影响不同,但均能减弱寡聚体诱导的膜通透性。
Biochemistry. 2009 Sep 22;48(37):8908-19. doi: 10.1021/bi9006397.
8
Initial characterization of micafungin pulmonary delivery via two different nebulizers and multivariate data analysis of aerosol mass distribution profiles.通过两种不同雾化器进行米卡芬净肺部给药的初步表征及气溶胶质量分布曲线的多变量数据分析。
AAPS PharmSciTech. 2009;10(1):129-37. doi: 10.1208/s12249-009-9185-6. Epub 2009 Feb 3.
9
Liposomal dry powders as aerosols for pulmonary delivery of proteins.用于蛋白质肺部递送的脂质体干粉气雾剂。
AAPS PharmSciTech. 2005 Dec 21;6(4):E641-8. doi: 10.1208/pt060480.
10
Carrier-based strategies for targeting protein and peptide drugs to the lungs.将蛋白质和肽类药物靶向输送至肺部的基于载体的策略。
AAPS J. 2005 Mar 24;7(1):E20-41. doi: 10.1208/aapsj070104.
Pharm Res. 1990 Nov;7(11):1127-33. doi: 10.1023/a:1015924124180.
4
Nebulization of liposomes. II. The effects of size and modeling of solute release profiles.脂质体雾化。II. 溶质释放曲线的大小和模型的影响。
Pharm Res. 1991 Feb;8(2):217-21. doi: 10.1023/a:1015896121377.